![]() |
Up a level |
Vulsteke, Christof; Pfeil, Alena M; Maggen, Charlotte; Schwenkglenks, Matthias; Pettengell, Ruth; Szucs, Thomas D; Lambrechts, Diether; Dieudonné, Anne-Sophie; Hatse, Sigrid; Neven, Patrick; Paridaens, Robert; Wildiers, Hans (2015). Clinical and genetic risk factors for epirubicin-induced cardiac toxicity in early breast cancer patients. Breast Cancer Research and Treatment, 152(1):67-76.
Vulsteke, Christof; Pfeil, Alena M; Schwenkglenks, Matthias; Pettengell, Ruth; Szucs, Thomas D; Lambrechts, Diether; Peeters, Marc; van Dam, Peter; Dieudonné, Anne-Sophie; Hatse, Sigrid; Neven, Patrick; Paridaens, Robert; Wildiers, Hans (2014). Impact of genetic variability and treatment-related factors on outcome in early breast cancer patients receiving (neo-) adjuvant chemotherapy with 5-fluorouracil, epirubicin and cyclophosphamide, and docetaxel. Breast Cancer Research and Treatment, 147(3):557-70.
Pfeil, Alena M; Vulsteke, Christof; Paridaens, Robert; Dieudonné, Anne-Sophie; Pettengell, Ruth; Hatse, Sigrid; Neven, Patrick; Lambrechts, Diether; Szucs, Thomas D; Schwenkglenks, Matthias; Wildiers, Hans (2014). Multivariable regression analysis of febrile neutropenia occurrence in early breast cancer patients receiving chemotherapy assessing patient-related, chemotherapy-related and genetic risk factors. BMC Cancer, 14:201.